Big news in the fertility world this morning. Gameto, the pluripotent stem cell startup I wrote about in my future of fertility series last year, was acquired by Ferring (pharma co) for $1.4b! It uses stem cells to essentially regenerate dysfunctional or aging eggs in women’s ovaries. I imagine this biotech will now became a standard part of IVF care, and as I wrote last year, it also has promising implications for aging-related symptoms of menopause too.
https://t.co/lNCRouKrcY
Ferring has signed a $1.4 billion deal to buy Gameto, a biotech company best known for its product that aims to improve egg freezing for women. https://t.co/A7OlbqE9sx
Gameto represents the kind of breakthrough science that has the potential to fundamentally change women’s health and expand reproductive choice for generations to come. With decades of experience helping people build families, Ferring is well positioned to bring this innovation to more women and families around the world.
An important milestone for @OverwaterVC's portfolio company, @GametoGen. Today, Gameto and Ferring Pharmaceuticals have signed an agreement for a proposed acquisition of up to $1.38B. Congratulations to @drdinaturner, @martinvars, and the entire team! https://t.co/eKEc5OUkXK
Ferring Pharma, one of the biggest sellers of fertility drugs used in IVF, plans to acquire the ovary-in-a-dish startup Gameto for up to $1.38B.
Gameto has made iPSC-derived ovarian support cells that help mature human eggs in the lab. Read more @endpts: https://t.co/OuUpCh7HzY
Gameto has signed an agreement under which Ferring Pharmaceuticals would acquire the company. Completion remains subject to customary and other closing conditions.
https://t.co/gsUrypjxf5
An important milestone for @OverwaterVC's portfolio company, @GametoGen. Today, Gameto and Ferring Pharmaceuticals have signed an agreement for a proposed acquisition of up to $1.38B. Congratulations to @drdinaturner, @martinvars, and the entire team!
Thanks to Jim Messina and Lindsey Kerr for joining today to talk about The Political Landscape: What It Means for Capital, Innovation, & Regulation with our @Overwatervc founders for our latest On the Dock session!
Austin-based Tiny Health has raised $33 million in a Series B funding round led by B Capital to help it meet growing demand for its at-home microbiome tests.
https://t.co/DUrtRxoFjW
Check out @OverwaterVC featured in @Forbes, including our take on AI and where we see the biggest opportunities ahead! Thanks @TheAlexKnapp for including us. https://t.co/s1qMzJh8bm
One of the fastest growing companies in America. Congrats @overstoryai and @fionaspruill!!!
#151 on the 2026 Inc. 5000. Six of the ten largest US electric utilities are customers to use AI to reduce wildfires and power outages.
@OverwaterVC
https://t.co/dloB41VO6m
Incredible progress from @OlioLabsInc. A smarter, faster way to predict how a drug will actually work in people before it ever reaches a clinical trial.
We’re bringing predictive validity to drug discovery’s most unpredictable stage. Today we are introducing Olio Labs’ in vivo platform, designed to predict diverse human clinical outcomes from a single high-throughput experiment. (1/n)
Thrilled to bring on @Ashworth_SF to the team. From the discovery of BRCA2 to leading @UCSFCancer, Alan has spent decades advancing breakthrough science and cancer care. Excited to have his perspective helping us support the next generation of transformative companies.
We had our first-ever @OverwaterVC offsite last week.
A big thank you to our growing Overwater team for spending time together pushing the limits of what is possible for the future!
Big waves ahead. 🌊
@ksimm@carolyncoles@Ashworth_SF
Neurosurgeon & @OverwaterVC portfolio CEO Dr. Casey Halpern joins @hubermanlab to reveal the groundbreaking science of rewiring the brain to treat OCD, addiction, compulsive behaviours and more. https://t.co/E3VVhX85SB